Stock listing
RHHBY Stock Price, News, Filings & Events — Roche Holding Ltd
Selected listing: RHHBY · OTC · USD · US
This page tracks Roche Holding Ltd's RHHBY:OTC listing on OTC in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following RHHBY:OTC. RHHBY:OTC is the stock-level entry point for investors researching Roche Holding Ltd, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Roche Holding Ltd is a prominent public company based in Switzerland, with a market capitalization of approximately 341.1 billion Swiss francs. The company is known for its contributions to the healthcare sector, focusing on pharmaceuticals and diagnostics. Roche is committed to innovation and improving patient outcomes through its extensive research and development efforts.
- Ticker
- RHHBY:OTC
- Asset type
- Stock
- Market cap
- $349.32B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- OTC
- Currency
- USD
Roche Holding Ltd RHHBY:OTC stock context
This page tracks Roche Holding Ltd's RHHBY:OTC listing on OTC in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following RHHBY:OTC. RHHBY:OTC is the stock-level entry point for investors researching Roche Holding Ltd, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Roche Holding Ltd is a prominent public company based in Switzerland, with a market capitalization of approximately 341.1 billion Swiss francs. The company is known for its contributions to the healthcare sector, focusing on pharmaceuticals and diagnostics. Roche is committed to innovation and improving patient outcomes through its extensive research and development efforts.
Latest news from Roche Holding Ltd
Genentech Announces Positive Phase II Results for Dual GLP-1/GIP Receptor Agonist Enicepatide in People Living With Type 2 Diabetes and Overweight or Obesity
September 22, 2026
CHMP recommends EU approval of Roche’s Ocrevus for children and adolescents with relapsing multiple sclerosis
September 18, 2026
Genentech and Roche Announce Grand Opening of Boston R&D Innovation Center
September 17, 2026
Genentech’s Lunsumio-Based Regimen Significantly Improves Progression-Free Survival in Follicular Lymphoma in Phase III CELESTIMO Study
September 17, 2026
U.S. FDA grants Priority Review for Roche’s Enspryng for MOGAD, an autoimmune disease with no approved treatments
September 10, 2026
Roche Holding Ltd earnings calls
Roche Holding AG (RHHBY) Q2 2026 Earnings Call
July 23, 2026 · Replay with transcript and chapters
Roche Holding AG (RHHBY) Q1 2026 Earnings Call
April 23, 2026 · Replay with transcript and chapters
Roche Holding AG (RHHBY) Q4 2025 Earnings Call
January 29, 2026 · Replay with transcript and chapters
Roche Holding AG (RHHBY) Q3 2025 Earnings Call
October 23, 2025 · Replay with transcript and chapters
Roche Holding AG (RHHBY) Q2 2025 Earnings Call
July 24, 2025 · Replay with transcript and chapters
Roche Holding AG (RHHBY) Q1 2025 Earnings Call
April 24, 2025 · Replay with transcript and chapters
Research Roche Holding Ltd
Roche Holding Ltd investor report
Review AI stock analysis and investor report context for RHHBY:OTC.
Roche Holding Ltd company profile
View the public company page for Roche Holding Ltd on 6ix.
Roche Holding Ltd news
Read company news and market updates connected to Roche Holding Ltd.
Roche Holding Ltd investor events
Find investor webinars, events, and replay context for Roche Holding Ltd.
Alternate listings
RO:SIX
CH · CHF
Alternate listing for Roche Holding Ltd; the primary context on this page is RHHBY:OTC.
ROP:SIX
CH · CHF
Alternate listing for Roche Holding Ltd; the primary context on this page is RHHBY:OTC.
RHO:XETR
DE · EUR
Alternate listing for Roche Holding Ltd; the primary context on this page is RHHBY:OTC.
RHHVF:OTC
US · USD
Alternate listing for Roche Holding Ltd; the primary context on this page is RHHBY:OTC.
1RO:MIL
IT · EUR
Alternate listing for Roche Holding Ltd; the primary context on this page is RHHBY:OTC.
RHO:GETTEX
DE · EUR
Alternate listing for Roche Holding Ltd; the primary context on this page is RHHBY:OTC.
RHHBF:OTC
US · USD
Alternate listing for Roche Holding Ltd; the primary context on this page is RHHBY:OTC.
0QOK:LSIN
GB · CHF
Alternate listing for Roche Holding Ltd; the primary context on this page is RHHBY:OTC.
0QQ6:LSE
GB · CHF
Alternate listing for Roche Holding Ltd; the primary context on this page is RHHBY:OTC.
ROP:BX
CH · CHF
Alternate listing for Roche Holding Ltd; the primary context on this page is RHHBY:OTC.
ROGH:VIE
AT · EUR
Alternate listing for Roche Holding Ltd; the primary context on this page is RHHBY:OTC.
ROG:TSX
CA · CAD
Alternate listing for Roche Holding Ltd; the primary context on this page is RHHBY:OTC.